• MRNA Vaccines for the Win; But mRNA Therapies.?

    10 days ago - By IEEE Spectrum

    Moderna, the company behind one of the best-selling COVID-19 vaccines in the world, is trying to prove that its messenger RNA platform is not a one-trick pony. Earlier this month, the biotech firm announced that an experimental mRNA therapy, called AZD8601, was well tolerated and showed hints of efficacy when injected directly into the hearts of seven people undergoing coronary artery bypass surgery. It was the first demonstration in Moderna's 11-year history that the company's mRNA molecules could safely produce functional proteins that directly exert a therapeutic effect inside the body...
    Read more ...